Breaking News

Boehringer Ingelheim Adopts Veeva Vault CRM

Selects the next generation of CRM for life sciences as its commercial foundation for future expansion and launches.

Author Image

By: Charlie Sternberg

Associate Editor

Boehringer Ingelheim has become the latest global top 20 biopharma company to commit to moving to Veeva Vault CRM.   “We are excited to bring our innovative research to patients around the world with up to 25 new treatment launches by 2030. Veeva has been our global CRM standard for many years, and we are eager to build on our successful partnership and help shape the future of life sciences with a commitment to move to Veeva Vault CRM,” said Uday Bose, head of human pharma global ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters